$ACAD

$20.46▲ -1.1% YTD

3 SEC 13D/G filings tracked · Last updated Sep 28, 2026

Filing History

ACAD ▼ -1.1% - Acadia Pharmaceuticals Inc.

CP $20.46▲ -1.1%Sep 28, 2026 · ThinkSabio Blog

$ACAD Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to Mar…

News

ACAD ▼ -19.5% - ACADIA Pharmaceuticals Inc.

CP $20.50▲ -19.5%Sep 24, 2026 · ThinkSabio Blog

$ACAD Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s D…

SEC 13D/G

ACAD - ACADIA Pharmaceuticals Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$28.13▲ 6.96%Aug 7, 2026 · ThinkSabio Blog

$ACAD SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACAD ACADIA Pharmaceuticals Inc. : $28.13 Sector: Healthcare |…